- May 17, 2012
- 01:37 PM CET
- search
- T&C's
- Disclaimer
- PRIVACY POLICY
- Imprint
- RSS
- ©2012 EVOTEC
- Loading...
Archive
Evotec Becomes the First Contract Research Facility in Europe to Offer Agilent's RapidFire/MS Screening for Pharmaceutical Drug Discovery
16 May 2012: Evotec AG is proud to announce the addition of Agilent Technologies’ RapidFire Mass Spectrometry analysis capabilities to their High Throughput Screening facilities in Hamburg.
- read more
Evotec reports continued strong revenue growth in Q1 2012
Hamburg, Germany - 10 May 2012: Evotec AG today reported financial results and corporate updates for the first quarter of 2012.
Evotec AG and 4-Antibody AG form strategic collaboration to innovate antibody selection
Hamburg, Germany; Basel, Switzerland - 09 May 2012: Evotec AG and 4-Antibody AG today announced the signing of a strategic collaboration agreement under which Evotec will offer a fully integrated antibody discovery and development service. ...
- read moreEvotec AG announces multi-year agreement with The United States Environmental Protection Agency (EPA)
Hamburg, Germany - 03 May 2012: Evotec AG today announced that Evotec has entered into a multi-year compound management agreement with the United States EPA. ...
- read moreEvotec grants exclusive rights on EVT 401 in China to Conba Pharmaceutical
Hamburg, Germany - 02 May 2012: Evotec AG and Conba Pharmaceutical Co., Ltd. announced today the grant of a development and marketing license on EVT 401. ...
- read moreEvotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration
Hamburg, Germany - 26 April 2012: Evotec AG today announced that it has extended and expanded its medicinal chemistry collaboration with Active Biotech AB. ...
- read moreEvotec publishes DDup 2 – neurodegenerative diseases
Hamburg, Germany - 24 April 2012: Evotec AG today announced the publication of its second edition of DDup. ...
- read moreEvotec FY 2011: Significant Growth and Focused Investments Drive Profitability and Innovation
Hamburg, Germany - 20 March 2012: Evotec AG today reported financial results and corporate updates for the year ended 31 December 2011. ...
- read moreEvotec and IR Pharma Establish Drug Discovery Alliance in the Field of Respiratory
16 February 2012: Evotec AG and IR Pharma today announced that they have entered into an exclusive strategic alliance. ...
- read moreSqueeze-out process for DeveloGen completed
24 January 2012: Evotec AG today announced the completion of the squeeze-out process to acquire all of the remaining shares of DeveloGen AG from its minority
shareholders.
Evotec and Harvard University Expand Strategic Alliance into Kidney Disease
17 January 2012: Evotec AG today announced a second strategic alliance with Harvard University, this time including Brigham and Women's Hospital aimed at discovering and developing new biomarkers and treatments in the field of kidney disease.
- read moreEvotec Receives 4th Milestone Payment in 2011 as Part of its Discovery Alliance with Boehringer Ingelheim
11 January 2012: Evotec AG today announced that its research alliance with Boehringer Ingelheim has achieved a milestone triggering a payment of EUR 2.5 million
to Evotec.